Condition (MeSH)
Opsoclonus-Myoclonus Syndrome
ClinicalTrials.gov lists 5 trials for Opsoclonus-Myoclonus Syndrome or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Opsoclonus-Myoclonus Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Opsoclonus-Myoclonus Syndrome trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 3
- Observational
Top of scale: 2
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2013 | 1 |
| 2008 | 2 |
| 2005 | 2 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Opsoclonus-Myoclonus Syndrome trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Observational | 1 |
How many Opsoclonus-Myoclonus Syndrome trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 3 |
| Terminated | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which serious adverse events do Opsoclonus-Myoclonus Syndrome trials report? (1)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Febrile illness with upper respiratory symptoms and dehydration | 1 | 1 |
Which publications cover Opsoclonus-Myoclonus Syndrome? (12)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. | The Lancet. Child & adolescent health | 2018 | Yes |
| CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders. | Journal of neuroimmunology | 2014 | Yes |
| BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy. | Journal of neuroinflammation | 2013 | Yes |
| CCR4 agonists CCL22 and CCL17 are elevated in pediatric OMS sera: rapid and selective down-regulation of CCL22 by ACTH or corticosteroids. | Journal of clinical immunology | 2013 | Yes |
| Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders. | Journal of the neurological sciences | 2013 | Yes |
Showing 5 of 12 publications.
Prevalence (9)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Opsoclonus-myoclonus syndrome | Annual incidence | <1 / 1 000 000 | United Kingdom | GB | Unspecified |
| Opsoclonus-myoclonus syndrome | Annual incidence | <1 / 1 000 000 | United Kingdom | GB | Exact |
| Opsoclonus-myoclonus syndrome | Annual incidence | <1 / 1 000 000 | United Kingdom | GB | Exact |
| Opsoclonus-myoclonus syndrome | Point prevalence | Unknown | Worldwide | Not stated | Exact |
| Opsoclonus-myoclonus syndrome | Point prevalence | Unknown | Worldwide | Not stated | Unspecified |
Showing 5 of 9 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Opsoclonus-myoclonus syndrome | 1183 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Opsoclonus-myoclonus syndrome | 1183 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.